the obstetric implications of the use of the beta-adrenoceptor antagonist atenolol have been evaluated in a prospective , randomized , double-blind , and placebo-controlled study involving 120 women with pregnancy-associated hypertension .
C0001643
beta-adrenoceptor
C0020538
hypertension